&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2024-06-21, 23:29
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2024-05-29, 15:54
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2024-05-10, 21:58
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2024-04-02, 18:42
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2024-02-05, 20:59
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-10-31, 16:16
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-07-21, 13:15
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-17, 04:09
Predicine to Present Four Studies at 2023 ASCO
HAYWARD, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, is committed to advancing genitourinary (GU) cancer...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-14, 18:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-06, 13:20
Sandoz Biologics License Application for proposed
Submission supported by comprehensive analytical and clinical data package Denosumab indicated for treating variety of conditions including...
